{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.7","meta":{"versionId":"9","lastUpdated":"2023-04-03T14:03:53.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CancerLinQ Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-04-03"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.7","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.7"}],"version":"20150528","name":"HepatitisBAntigenTest","title":"Hepatitis B Antigen Test","status":"active","experimental":false,"date":"2022-03-03T18:46:01-05:00","publisher":"CancerLinQ Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.5"]},{"valueSet":["http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.32"]}]},"expansion":{"identifier":"urn:uuid:0e4380f1-b4f1-436c-9db0-bde914db0cd4","timestamp":"2023-12-10T21:43:52-05:00","total":6,"contains":[{"system":"http://snomed.info/sct","version":"http://snomed.info/sct/731000124108/version/20230901","code":"313476009","display":"Hepatitis B e antigen test (procedure)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"87340","display":"Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; hepatitis B surface antigen (HBsAg)"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"87341","display":"Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; hepatitis B surface antigen (HBsAg) neutralization"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"87516","display":"Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, amplified probe technique"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"87517","display":"Infectious agent detection by nucleic acid (DNA or RNA); hepatitis B virus, quantification"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"87912","display":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis B virus"}]}}